Initial experience using a laser-balloon endoscopic catheter for the treatment of patients with paroxysmal atrial fibrillation
Authors:
J. Škoda 1; P. Neužil 1; V. Y. Reddy 2; J. Petrů 1; L. Šedivá 1; M. Táborský 1; A. Raviele 3; S. Ernst 4; K. H. Kuck 4; A. Natale 5
Authors‘ workplace:
Kardiologické oddělení Nemocnice Na Homolce, Praha
1; Massachusetts General Hospital, Boston, USA
2; Umberto Hospital, Venice, Itálie
3; St. Georg Hospital, Hamburg, Německo
4; Cleveland Foundation Hospital, Cleveland, USA
5
Published in:
Prakt. Lék. 2007; 87(10): 618-623
Category:
Of different specialties
Overview
Background:
During catheter ablation of atrial fibrillation (AF), placing contiguous point ablation lesions to electrically-isolate the pulmonary veins (PV) can be technically challenging. A novel balloon catheter (Endoscopic Ablation System – EAS; Cardiofocus, Inc.) which utilizes a miniature endoscope for real-time visualization during ablation has been developed. This system employs arcs of light-energy that are adjustable (rotating, advancing, retracting) independent of the balloon to direct energy to the pulmonary veins PV-left atrium(LA) region. This report details the first clinical long-term follow-up results from a prospective multicentric trial in patients from our center.
Methods:
22 patients with a history of symptomatic drug-resistant paroxysmal AF were studied: Sex: M/F = 19/3; Age 53 ± 8 years (29–73); AF duration: 7.0 ± 3.0 years (1–14); LA diameter: 42 ± 4 mm (33–49); left ventricular ejection fraction (LVEF) 68 ± 4% (45–77). A single treatment consisting of isolation of the PV ostia was delivered using the EAS. There were no exclusion criteria related to morphology/number of PVs
Results:
During long-term follow-up 17.1 ± 6.6 months (7–27) AF free endpoint was achieved in 19 (86.3%) patients, of whom 7 (33 %) patients needed adjunctive betablocker and/or propafenon. Three patients (13.6 %) experienced AF despite antiarrhythmic therapy, the procedure was successfully repeated in one patient. During 6 to 12 moths follow-up visits, a computed tomography revealed only mild stenosis 26.4 ± 4,4 % (20–37) in 16 % of PVs. Two adverse events were documented: transient ischemic attack, and pseudoaneurysm of a right femoral artery solved by a percutaneous glue-tissue application. The time of procedure + fluoroscopy significantly decreased during a learning curve.
Conclusion:
This initial clinical-feasibility study suggests that a single treatment with the EAS of paroxysmal AF appears safe and efficacious.
Key words:
paroxysmal atrial fibrillation, catheter ablation, transseptal puncture, pulmonary vein isolation, light-energy laser arc.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2007 Issue 10
Most read in this issue
- Urological complications of gynaecologic surgery
- Posttraumatic stress disorder (PTSD)
- Pneumothorax. Overview and current therapeutic options.
- Hemochromatosis – a current review